We have previously reported that the treatment of bladder cancer cells with the chemotherapeutic drug cisplatin induces Oct4 expression, leading to the acquisition of cancer stem cell phenotypes and resistance to cisplatin [16]. The gene discussed is POU5F1; the disease is urinary bladder carcinoma.